7
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Rate and impact of duodenoscope contamination: A systematic review and meta-analysis

      research-article
      a , * , a , a , b , c , d , e
      EClinicalMedicine
      Elsevier
      Duodenoscopes, Cross infection, Equipment contamination, Drug Resistance, Multiple, Bacterial*, Infection Control, AGA, American Gastroenterological Association, AORN, The Joint Commission and The Association of Perioperative Registered Nurses, CRE, carbapenem-resistant Enterobacteriaceae, CDC, Center for Disease Control and Prevention, Cl, confidence interval, CFU, colony-forming units, dHLD, double high-level disinfection, ERCI, Environmental Risk Communications, Inc., ERCP, endoscopic retrograde cholangio-pancreatography, EtO, ethylene oxide, FDA, Food & Drug Administration, HLD, high-level disinfection, MDR, multi-drug-resistant, MeSH, medical subject headings, PRISMA, Preferred Reporting Items for Systematic Reviews and Meta-Analyses, REM, random-effects model

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Multiple infection outbreaks have been linked to contaminated duodenoscopes worldwide. However, the contamination rate of patient-ready duodenoscopes varies highly amongst published studies testing this subject. We aimed to estimate the contamination rate of reprocessed patient-ready duodenoscopes for endoscopic retrograde cholangio-pancreatography (ERCP) based on currently available data.

          Methods

          We searched the PubMed and Embase databases from January 1, 2010 until March 10, 2020, for citations investigating contamination rates of reprocessed patient-ready duodenoscopes. Studies not assessing other types of endoscopes than duodenoscopes were excluded from the analysis. Study eligibility and data extraction was evaluated by three reviewers independently. A random-effects model (REM) based on the proportion distribution was used to calculate the pooled total contamination rate of reprocessed patient-ready duodenoscopes. Subgroup analyses were carried out to assess contamination rates when using different reprocessing methods by comparing single high-level disinfection (HLD) with double HLD and ethylene oxide (EtO) gas sterilization. Additionally, we investigated the contamination rate between studies conducted following an outbreak compared to non-outbreak-initiated studies.

          Findings

          We identified 15 studies that fulfilled the inclusion, which included 925 contaminated duodenoscopes from 13,112 samples. The calculated total weighted contamination rate was 15.25% ± 0.018 (95% confidence interval [Cl]: 11.74% - 18.75%). The contamination rate after only using HLD was 16.14% ± 0.019 (95% Cl: 12.43% - 19.85%) and after using either dHLD or EtO the contamination rate decreased to 9.20% ± 0.025 (95% Cl: 4.30% - 14.10%). Studies conducted following an outbreak (n=4) showed a 5.72% ± 0.034 (95% Cl: 0.00% - 12.43%) contamination rate, and non-outbreak-initiated studies (n=11) revealed a contamination rate of 21.50% ± 0.031 (95% Cl: 15.35% - 27.64%).

          Interpretation

          This is the first meta-analysis to estimate the contamination rate of patient-ready duodenoscopes used for ERCP. Based on the available literature, our analysis demonstrates that there is a 15.25% contamination rate of reprocessed patient-ready duodenoscopes. Additionally, the analysis indicates that dHLD and EtO reprocessing methods are superior to single HLD but still not efficient in regards to cleaning the duodenoscopes properly. Furthermore, studies conducted following an outbreak did not entail a higher contamination rate compared to non-outbreak-initiated studies.

          Funding

          The authors received no financial support for the research, authorship, and/or publication of this article.

          Related collections

          Most cited references40

          • Record: found
          • Abstract: not found
          • Article: not found

          Complications of ERCP.

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Prevalence and burden of hepatitis D virus infection in the global population: a systematic review and meta-analysis

            Hepatitis D virus (HDV) is a defective virus that completes its life cycle only with hepatitis B virus (HBV). The HBV with HDV super-infection has been considered as one of the most severe forms of the chronic viral hepatitis. However, there is a scarcity of data on the global burden of HDV infection. We searched PubMed, Embase, Cochrane Library and China Knowledge Resource Integrated databases from 1 January 1977 to 31 December 2016. We included studies with a minimum sample size of 50 patients. Our study analysed data from a total of 40 million individuals to estimate the prevalence of HDV by using Der-Simonian Laird random-effects model. The data were further categorised according to risk factors. From a total of 2717 initially identified studies, only 182 articles from 61 countries and regions met the final inclusion criteria. The overall prevalence of HDV was 0.98% (95% CI 0.61 to 1.42). In HBsAg-positive population, HDV pooled prevalence was 14.57% (95% CI 12.93 to 16.27): Seroprevalence was 10.58% (95% CI 9.14 to 12.11) in mixed population without risk factors of intravenous drug use (IVDU) and high-risk sexual behaviour (HRSB). It was 37.57% (95% CI 29.30 to 46.20) in the IVDU population and 17.01% (95% CI 10.69 to 24.34) in HRSB population. We found that approximately 10.58% HBsAg carriers (without IVDU and HRSB) were coinfected with HDV, which is twofold of what has been estimated before. We also noted a substantially higher HDV prevalence in the IVDU and HRSB population. Our study highlights the need for increased focus on the routine HDV screening and rigorous implementation of HBV vaccine programme.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              ASGE guideline for infection control during GI endoscopy

                Bookmark

                Author and article information

                Contributors
                Journal
                EClinicalMedicine
                EClinicalMedicine
                EClinicalMedicine
                Elsevier
                2589-5370
                15 July 2020
                August 2020
                15 July 2020
                : 25
                : 100451
                Affiliations
                [a ]Ambu A/S, Ambu A/S, Baltorpbakken 13, 2750 Ballerup, Denmark
                [b ]Anesthesia and Acute Pain Department of Anesthesia University of Utah Primary Children's Hospital, United States
                [c ]School of Medicine and Health, Aalborg University, Aalborg, Denmark
                [d ]Department of Business and Management, Danish Center for Healthcare Improvements, Aalborg University, Aalborg, Denmark
                [e ]Nordic HTA, Copenhagen, Denmark
                Author notes
                [* ]Corresponding author. sarl@ 123456ambu.com
                Article
                S2589-5370(20)30195-4 100451
                10.1016/j.eclinm.2020.100451
                7486302
                32954234
                13e4c224-415b-4b4d-8339-67faf4daf27c
                © 2020 The Authors

                This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

                History
                Categories
                Research Paper

                duodenoscopes,cross infection,equipment contamination,drug resistance,multiple,bacterial*,infection control,aga, american gastroenterological association,aorn, the joint commission and the association of perioperative registered nurses,cre, carbapenem-resistant enterobacteriaceae,cdc, center for disease control and prevention,cl, confidence interval,cfu, colony-forming units,dhld, double high-level disinfection,erci, environmental risk communications, inc.,ercp, endoscopic retrograde cholangio-pancreatography,eto, ethylene oxide,fda, food & drug administration,hld, high-level disinfection,mdr, multi-drug-resistant,mesh, medical subject headings,prisma, preferred reporting items for systematic reviews and meta-analyses,rem, random-effects model

                Comments

                Comment on this article